Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 340 (6132): 615-619

Copyright © 2013 by the American Association for the Advancement of Science

Structural Features for Functional Selectivity at Serotonin Receptors

Daniel Wacker,1 Chong Wang,1 Vsevolod Katritch,1 Gye Won Han,1 Xi-Ping Huang,2 Eyal Vardy,2 John D. McCorvy,2 Yi Jiang,1,3 Meihua Chu,1 Fai Yiu Siu,1 Wei Liu,1 H. Eric Xu,3,4 Vadim Cherezov,1 Bryan L. Roth,2,* Raymond C. Stevens1,*

Abstract: Drugs active at G protein–coupled receptors (GPCRs) can differentially modulate either canonical or noncanonical signaling pathways via a phenomenon known as functional selectivity or biased signaling. We report biochemical studies showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ERG), and related ergolines display strong functional selectivity for β-arrestin signaling at the 5-HT2B 5-hydroxytryptamine (5-HT) receptor, whereas they are relatively unbiased at the 5-HT1B receptor. To investigate the structural basis for biased signaling, we determined the crystal structure of the human 5-HT2B receptor bound to ERG and compared it with the 5-HT1B/ERG structure. Given the relatively poor understanding of GPCR structure and function to date, insight into different GPCR signaling pathways is important to better understand both adverse and favorable therapeutic activities.

1 Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
2 National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC 27599, USA.
3 Van Andel Research Institute/Shanghai Institute of Materia Medica Center, CAS-Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
4 Laboratory of Structural Sciences, Van Andel Research Institute, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA.

* Corresponding author. E-mail: bryan_roth{at}med.unc.edu (B.L.R.); stevens{at}scripps.edu (R.C.S.)


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Differential Effects of the G{beta}5-RGS7 Complex on Muscarinic M3 Receptor-Induced Ca2+ Influx and Release.
D. Karpinsky-Semper, C.-H. Volmar, S. P. Brothers, and V. Z. Slepak (2014)
Mol. Pharmacol. 85, 758-768
   Abstract »    Full Text »    PDF »
Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor.
A. Abdul-Ridha, L. Lopez, P. Keov, D. M. Thal, S. N. Mistry, P. M. Sexton, J. R. Lane, M. Canals, and A. Christopoulos (2014)
J. Biol. Chem. 289, 6067-6079
   Abstract »    Full Text »    PDF »
Identification of Novel Functionally Selective {kappa}-Opioid Receptor Scaffolds.
K. L. White, A. P. Scopton, M.-L. Rives, R. V. Bikbulatov, P. R. Polepally, P. J. Brown, T. Kenakin, J. A. Javitch, J. K. Zjawiony, and B. L. Roth (2014)
Mol. Pharmacol. 85, 83-90
   Abstract »    Full Text »    PDF »
Role of the N-Terminal Region in G Protein-Coupled Receptor Functions: Negative Modulation Revealed by 5-HT2B Receptor Polymorphisms.
A. Belmer, S. Doly, V. Setola, S. M. Banas, I. Moutkine, K. Boutourlinsky, T. Kenakin, and L. Maroteaux (2014)
Mol. Pharmacol. 85, 127-138
   Abstract »    Full Text »    PDF »
Serial Femtosecond Crystallography of G Protein-Coupled Receptors.
W. Liu, D. Wacker, C. Gati, G. W. Han, D. James, D. Wang, G. Nelson, U. Weierstall, V. Katritch, A. Barty, et al. (2013)
Science 342, 1521-1524
   Abstract »    Full Text »    PDF »
Kinetics of 5-HT2B Receptor Signaling: Profound Agonist-Dependent Effects on Signaling Onset and Duration.
D. J. Unett, J. Gatlin, T. L. Anthony, D. J. Buzard, S. Chang, C. Chen, X. Chen, H. T.- M. Dang, J. Frazer, M. K. Le, et al. (2013)
J. Pharmacol. Exp. Ther. 347, 645-659
   Abstract »    Full Text »    PDF »
Chemotype-selective Modes of Action of {kappa}-Opioid Receptor Agonists.
E. Vardy, P. D. Mosier, K. J. Frankowski, H. Wu, V. Katritch, R. B. Westkaemper, J. Aube, R. C. Stevens, and B. L. Roth (2013)
J. Biol. Chem. 288, 34470-34483
   Abstract »    Full Text »    PDF »
As Good as Chocolate.
K. Palczewski and P. D. Kiser (2013)
Science 340, 562-563
   Abstract »    Full Text »    PDF »
Structural Basis for Molecular Recognition at Serotonin Receptors.
C. Wang, Y. Jiang, J. Ma, H. Wu, D. Wacker, V. Katritch, G. W. Han, W. Liu, X.-P. Huang, E. Vardy, et al. (2013)
Science 340, 610-614
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882